Norway – Pharmaceutical products – 26/11087: Open tender contest for procurement of medicines and pharmacy products

Norway – Pharmaceutical products – 26/11087: Open tender contest for procurement of medicines and pharmacy products is a UK public-sector framework agreement managed by Orkland Kommune (NOR). It is expected to expire around November 2028. Orkland municipality invites tenderers to an open tender contest for a framework agreement for the delivery of medicines, pharmacy products. The framework agreement will be valid for 2 years, with an option for an extension for 1+1 year. The estimated value is approx. NOK 2.5 million excluding VAT per annum and approx. NOK 10 million excluding VAT over the maximum contract period. Further details on the procurement are in the tender documentation and the attached requirement specifications.

When does it re-tender?

The current term is expected to end around November 2028. The re-tender competition typically opens in the months before that date, so the practical window to prepare a bid is roughly February 2028 onward. It was awarded November 2026 for a 2-year term.

How to prepare a bid

A re-tender asks for the same building blocks every time. Have these ready before the notice publishes, most take weeks to assemble:

• Cyber Essentials, and Cyber Essentials Plus if the framework requires it
• Up-to-date insurances (employer, public and professional indemnity)
• Financial evidence: your latest accounts and turnover figures
• Two or three case studies mapped to this framework's scope
• Core policies: equality, health and safety, data protection
• A capacity statement showing you can deliver at the required volume
• DBS checks, professional registration and a safeguarding policy
• Confirm the exact re-tender dates against the source notice; frameworks are frequently extended.

Start a trial to follow this framework and be alerted before the window opens.

CPV codes covered

The Common Procurement Vocabulary codes that describe this framework's scope. Match these to your business to judge relevance.